Basic Information
Cystadrops
Regulatory Information
EMEA/H/C/003769
Authorised
January 18, 2017
9
December 12, 2024
Company Information
France
Immeuble le Wilson 70, avenue du Général de Gaulle 92800 Puteaux
RECORDATI RARE DISEASES
Drug Classification
Orphan Medicine
Active Substances Detail
EMA Resources
Detailed Information
Therapeutic Indication
### Therapeutic indication Cystadrops is indicated for the treatment of corneal cystine crystal deposits in adults and children from 2 years of age with cystinosis.
Overview Summary
This is a summary of the European public assessment report (EPAR) for Cystadrops. It explains how the Agency assessed the medicine to recommend its authorisation in the EU and its conditions of use. It is not intended to provide practical advice on how to use Cystadrops. For practical information about using Cystadrops, patients should read the package leaflet or contact their doctor or pharmacist.